Template:Immune sera and immunoglobulins: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
en>Whywhenwhohow add Sipavibart |
||
| Line 23: | Line 23: | ||
| group2 = [[Monoclonal antibody|Monoclonal antibodies]] | | group2 = [[Monoclonal antibody|Monoclonal antibodies]] | ||
| list2 = | | list2 = | ||
* [[Bezlotoxumab]] | |||
* [[Motavizumab]] | * [[Motavizumab]] | ||
* [[Nebacumab]] | * [[Nebacumab]] | ||
* [[Nirsevimab]] | |||
* [[Obiltoxaximab]] | |||
* [[Palivizumab]] | * [[Palivizumab]] | ||
* [[Raxibacumab]] | * [[Raxibacumab]] | ||
* [[Sipavibart]] | |||
* [[Tixagevimab/cilgavimab]] | |||
| belowstyle = background: transparent; padding: 0px; | | belowstyle = background: transparent; padding: 0px; | ||
| Line 35: | Line 40: | ||
[[Category:Drug templates by ATC]] | [[Category:Drug templates by ATC]] | ||
</noinclude> | </noinclude> | ||
Revision as of 02:28, 16 December 2024
| Immune sera and immunoglobulins (J06) | ||||
|---|---|---|---|---|
|
